194 related articles for article (PubMed ID: 32406565)
1. SCAI guidelines on device selection in Aorto-Iliac arterial interventions.
Feldman DN; Armstrong EJ; Aronow HD; Banerjee S; Díaz-Sandoval LJ; Jaff MR; Jayasuriya S; Khan SU; Klein AJ; Parikh SA; Rosenfield K; Shishehbor MH; Swaminathan RV; White CJ
Catheter Cardiovasc Interv; 2020 Oct; 96(4):915-929. PubMed ID: 32406565
[No Abstract] [Full Text] [Related]
2. SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use.
Klein AJ; Feldman DN; Aronow HD; Gray BH; Gupta K; Gigliotti OS; Jaff MR; Bersin RM; White CJ;
Catheter Cardiovasc Interv; 2014 Oct; 84(4):520-8. PubMed ID: 24740523
[TBL] [Abstract][Full Text] [Related]
3. Aorto-iliac peripheral artery disease.
Javed IN; Hawkins BM
Prog Cardiovasc Dis; 2021; 65():9-14. PubMed ID: 33631164
[TBL] [Abstract][Full Text] [Related]
4. Intravenous intravascular ultrasound using the AcuNav ultrasound catheter for guiding recanalization of aortoiliac chronic total occlusions.
Hishikari K; Hikita H; Sugiyama T; Oumi T; Kimura S; Takahashi A; Isobe M
J Endovasc Ther; 2015 Apr; 22(2):269-71. PubMed ID: 25809374
[No Abstract] [Full Text] [Related]
5. One-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y; Takahara M; Shintani Y; Iida O; Sugano T; Yamamoto Y; Kawasaki D; Fujihara M; Hirano K; Yokoi H; Miyamoto A; Nakamura M;
Circ Cardiovasc Interv; 2019 Jan; 12(1):e007441. PubMed ID: 30616363
[No Abstract] [Full Text] [Related]
6. Drug-eluting stents in superficial femoral artery treatment: could they be the standard of care?
Bosiers M; Deloose K; Callaert J; Peeters P; Bosiers M
J Cardiovasc Surg (Torino); 2016 Dec; 57(6):806-810. PubMed ID: 27647337
[TBL] [Abstract][Full Text] [Related]
7. Intervention of Prohibitive Aortic and Iliac Atherosclerotic Stenosis to Allow Successful Transfemoral Transcatheter Aortic Valve Replacement.
Sanghvi K; Singh M
JACC Cardiovasc Interv; 2018 Sep; 11(17):e137-e140. PubMed ID: 30121283
[No Abstract] [Full Text] [Related]
8. SCAI consensus guidelines for device selection in femoral-popliteal arterial interventions.
Feldman DN; Armstrong EJ; Aronow HD; Gigliotti OS; Jaff MR; Klein AJ; Parikh SA; Prasad A; Rosenfield K; Shishehbor MH; Swaminathan RV; White CJ
Catheter Cardiovasc Interv; 2018 Jul; 92(1):124-140. PubMed ID: 29691970
[No Abstract] [Full Text] [Related]
9. In vivo geometry of the kissing stent and covered endovascular reconstruction of the aortic bifurcation configurations in aortoiliac occlusive disease.
Groot Jebbink E; Ter Mors TG; Slump CH; Geelkerken RH; Holewijn S; Reijnen MM
Vascular; 2017 Dec; 25(6):635-641. PubMed ID: 28530484
[TBL] [Abstract][Full Text] [Related]
10. Three-Year Outcomes of Endovascular Therapy for Aortoiliac Lesions.
Yamauchi Y; Takahara M; Shintani Y; Iida O; Sugano T; Yamamoto Y; Kawasaki D; Fujihara M; Hirano K; Soga Y; Tsubakimoto Y; Yokoi H; Miyamoto A; Nakamura M
Circ Cardiovasc Interv; 2020 Aug; 13(8):e009168. PubMed ID: 32755323
[No Abstract] [Full Text] [Related]
11. Independent predictors of loss of primary patency at 1 year after aortoiliac stent implantation.
Yamauchi Y; Takahara M; Iida O; Shintani Y; Sugano T; Yamamoto Y; Kawasaki D; Fujihara M; Soga Y; Hirano K; Yokoi H; Miyamoto A; Nakamura M;
Heart Vessels; 2020 May; 35(5):614-619. PubMed ID: 31642981
[TBL] [Abstract][Full Text] [Related]
12. SCAI appropriate use criteria for peripheral arterial interventions: An update.
Klein AJ; Jaff MR; Gray BH; Aronow HD; Bersin RM; Diaz-Sandoval LJ; Dieter RS; Drachman DE; Feldman DN; Gigliotti OS; Gupta K; Parikh SA; Pinto DS; Shishehbor MH; White CJ
Catheter Cardiovasc Interv; 2017 Oct; 90(4):E90-E110. PubMed ID: 28489285
[No Abstract] [Full Text] [Related]
13. Meta-analysis of Individual Patient Data After Kissing Stent Treatment for Aortoiliac Occlusive Disease.
Groot Jebbink E; Holewijn S; Versluis M; Grimme F; Hinnen JW; Sixt S; Angle JF; Dorigo W; Reijnen MMPJ
J Endovasc Ther; 2019 Feb; 26(1):31-40. PubMed ID: 30499352
[TBL] [Abstract][Full Text] [Related]
14. Endovascular revascularization for aortoiliac atherosclerotic disease.
Aggarwal V; Waldo SW; Armstrong EJ
Vasc Health Risk Manag; 2016; 12():117-27. PubMed ID: 27099509
[TBL] [Abstract][Full Text] [Related]
15. Outcome Comparison between Open and Endovascular Management of TASC II D Aortoiliac Occlusive Disease.
Mayor J; Branco BC; Chung J; Montero-Baker MF; Kougias P; Mills JL; Gilani R
Ann Vasc Surg; 2019 Nov; 61():65-71.e3. PubMed ID: 31394230
[TBL] [Abstract][Full Text] [Related]
16. Rotational Atherectomy Plus Drug-Coated Balloon Angioplasty for the Treatment of Total In-Stent Occlusions in Iliac and Infrainguinal Arteries.
Milnerowicz A; Milnerowicz A; Kuliczkowski W; Protasiewicz M
J Endovasc Ther; 2019 Jun; 26(3):316-321. PubMed ID: 30907258
[TBL] [Abstract][Full Text] [Related]
17. Nine-Month Outcomes of the DURABILITY Iliac Study on Self-Expanding Stents for Symptomatic Peripheral Artery Disease.
Faries P; Jaff M; Peeters P; Khatib Y; Roberts D; Bosiers M; Malik R; Ravin R; Rundback J
Ann Vasc Surg; 2018 Aug; 51():37-47. PubMed ID: 29678649
[TBL] [Abstract][Full Text] [Related]
18. Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results.
Deloose K; Bosiers M; Callaert J; Verbist J; Vermassen F; Scheinert D; Torsello G; Peeters P
J Cardiovasc Surg (Torino); 2017 Jun; 58(3):416-421. PubMed ID: 25331010
[TBL] [Abstract][Full Text] [Related]
19. Latest developments in SFA management.
Minar E
J Cardiovasc Surg (Torino); 2014 Aug; 55(4):451-3. PubMed ID: 24941244
[No Abstract] [Full Text] [Related]
20. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty.
Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M
Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
